ARGOS THERAPEUTICS INC Contracts & Agreements

Retention Agreement, dated July 20, 2018, by and between the Registrant and Jeffrey D. Abbey (Filed With SEC on November 19, 2018)

Retention Agreement, dated July 20, 2018, by and between the Registrant and Richard Katz (Filed With SEC on November 19, 2018)

Retention Agreement, dated July 20, 2018, by and between the Registrant and Charles Nicolette (Filed With SEC on November 19, 2018)

Release of Claims Agreement, dated July 20, 2018, by and between the Registrant and Jeffrey D. Abbey (Filed With SEC on November 19, 2018)

Release of Claims Agreement, dated July 20, 2018, by and between the Registrant and Richard Katz (Filed With SEC on November 19, 2018)

Release of Claims Agreement, dated July 20, 2018, by and between the Registrant and Charles Nicolette (Filed With SEC on November 19, 2018)

Consulting Agreement, dated August 29, 2018, by and between the Registrant and Jeffrey D. Abbey (Filed With SEC on November 19, 2018)

Consulting Agreement, dated August 29, 2018, by and between the Registrant and Richard Katz (Filed With SEC on November 19, 2018)

Consulting Agreement, dated August 29, 2018, by and between the Registrant and Charles Nicolette (Filed With SEC on November 19, 2018)

Letter from the Registrant to Medinet Co., Ltd., dated February 14, 2018, regarding revocation of certain rights under the novated, amended and restated license agreement (Filed With SEC on May 15, 2018)

Option Agreement, dated February 1, 2018, by and between the Registrant, Pharmstandard International S.A. and Actigen Limited (Filed With SEC on April 2, 2018)

Second Amendment to License Agreement, dated October 18, 2017, between Registrant and Lummy (Hong Kong) Co., Ltd (Filed With SEC on April 2, 2018)

Third Amendment to License Agreement, dated March 23, 2018, between Registrant and Lummy (Hong Kong) Co., Ltd (Filed With SEC on April 2, 2018)

Amended and Restated Sales Agreement, dated as of February 2, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on February 5, 2018)

Satisfaction and Release Agreement, dated November 22, 2017, by and between the Company and Saint-Gobain Performance Plastics Corporation, including a form of the Convertible... (Filed With SEC on November 28, 2017)

Registration Rights Agreement, dated November 22, 2017, by and between the Company and Saint-Gobain Performance Plastics Corporation (Filed With SEC on November 28, 2017)

Form of Restricted Stock Agreement under the 2014 Stock Incentive Plan (Filed With SEC on November 9, 2017)

Satisfaction and Release Agreement, dated September 22, 2017, by and between the Company and Invetech Pty Ltd, including a form of the Convertible Unsecured Promissory Note to be... (Filed With SEC on September 25, 2017)

Registration Rights Agreement, dated September 22, 2017, by and between the Company and Invetech Pty Ltd (Filed With SEC on September 25, 2017)

Argos Therapeutics, Inc. 2014 Stock Incentive Plan, as amended (Filed With SEC on August 2, 2017)

NOTE PURCHASE AGREEMENT (Filed With SEC on June 16, 2017)

REGISTRATION RIGHTSAGREEMENT (Filed With SEC on June 16, 2017)

First Amendment to License Agreement, dated December 5, 2016, by and between Registrant and Lummy (Hong Kong) Co., Ltd (Filed With SEC on May 10, 2017)

Lease Termination Agreement, dated March 31, 2017, by and between Registrant and Keystone-Centennial II, LLC (Filed With SEC on May 10, 2017)

AMENDMENT NO. 3 TO FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 16, 2017)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SECOND AMENDMENT (Filed With SEC on March 16, 2017)

LEASE TERM SHEET (Filed With SEC on March 16, 2017)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission .Double asterisks denote omissions. (Filed With SEC on March 16, 2017)

ARGOS THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on March 6, 2017)

SIXTH AMENDMENT TO LEASE AGREEMENT ANDFIFTH AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on November 14, 2016)

AMENDMENT NO. 2 TO FIFTH AMENDED AND RESTATED REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on August 15, 2016)

ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM, NC 27704 (Filed With SEC on August 15, 2016)

FIFTH AMENDMENT TO LEASE AGREEMENT AND THIRD AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on August 15, 2016)

9,090,909 Shares of Common Stock and Warrants toPurchase 6,818,181 Shares of Common Stock Argos Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on July 29, 2016)

WARRANT AGREEMENT (Filed With SEC on July 29, 2016)

ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM, NC 27704 (Filed With SEC on July 11, 2016)

ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM, NC 27704 (Filed With SEC on May 16, 2016)

Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 30, 2016)

ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM, NC 27704 (Filed With SEC on March 30, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 7, 2016)

Void after 5:00 p.m. (New York time) on the [] day of March, 2021. (Filed With SEC on March 7, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 7, 2016)

SOC 25.55 (Filed With SEC on November 16, 2015)

Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 15, 2015)

Confidential Materials omitted and filed separately with theExhibit 10.27Securities and Exchange Commission. Double asterisks denote omissions. DEVELOPMENT AGREEMENT (Filed With SEC on March 31, 2015)

Confidential Materials omitted and filed separately with theExhibit 10.29Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 31, 2015)

PURCHASE AND SALE AGREEMENT BETWEEN TKC LXXII, LLC, a North Carolina limited liability company, (the Seller) AND ARGOS THERAPEUTICS, INC., a Delaware corporation (the Buyer)... (Filed With SEC on February 20, 2015)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 14, 2014)

VENTURE LOAN AND SECURITY AGREEMENT (Filed With SEC on September 30, 2014)

ARGOS THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on September 30, 2014)

LEASE AGREEMENT between TKC LXXII, LLC, a North Carolina limited liability company, as Landlord, and ARGOS THERAPEUTICS, INC., a Delaware corporation, as Tenant Date:August 18,... (Filed With SEC on August 22, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. RIDER TO LICENSE AGREEMENT (Filed With SEC on March 31, 2014)

[ ] Shares Argos Therapeutics, Inc. Common Stock PURCHASEAGREEMENT (Filed With SEC on January 21, 2014)

Signature(s) Guaranteed:Medallion Guarantee Stamp (Filed With SEC on January 21, 2014)

ARGOS THERAPEUTICS, INC. 2014 STOCK INCENTIVE PLAN (Filed With SEC on January 21, 2014)

ARGOS THERAPEUTICS, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on January 21, 2014)

ARGOS THERAPEUTICS, INC. Nonstatutory Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on January 21, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT byand between ARGOS... (Filed With SEC on January 21, 2014)

Acknowledgement and Agreement (Filed With SEC on January 21, 2014)

ARGOS THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 21, 2014)

FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 30, 2013)

ARGOS THERAPEUTICS, INC. STOCK OPTION PLAN (Filed With SEC on December 30, 2013)

ARGOS THERAPEUTICS, INC. 2008 STOCK INCENTIVE PLAN (Filed With SEC on December 30, 2013)

ARGOS THERAPEUTICS, INC. NOTICE OF INCENTIVE STOCK OPTION 2008 STOCK INCENTIVE PLAN (Filed With SEC on December 30, 2013)

ARGOS THERAPEUTICS, INC. NOTICE OF NONSTATUTORY STOCK OPTION 2008 STOCK INCENTIVE PLAN (Filed With SEC on December 30, 2013)

AGREEMENT (Filed With SEC on December 30, 2013)

ARGOS THERAPEUTICS, INC. 4233TECHNOLOGY DRIVE DURHAM, NC 27704 (Filed With SEC on December 30, 2013)

INDEMNIFICATION AGREEMENT [Note: Bracketed provisions to be included for directors appointed by investment funds] (Filed With SEC on December 30, 2013)

[ ] Shares ARGOS THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on February 16, 2012)

ARGOS THERAPEUTICS, INC. 2011 STOCK INCENTIVE PLAN (Filed With SEC on February 10, 2012)

[Note: Bracketed provisions to be included for directors appointed by investment funds] INDEMNIFICATION AGREEMENT (Filed With SEC on February 10, 2012)

LICENSE AGREEMENT (Filed With SEC on February 10, 2012)

ARGOS THERAPEUTICS, INC. 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 6, 2012)

ARGOS THERAPEUTICS, INC. Incentive Stock Option Agreement Granted Under 2011 Stock Incentive Plan (Filed With SEC on January 6, 2012)

ARGOS THERAPEUTICS, INC. Nonstatutory Stock Option Agreement Granted Under 2011 Stock Incentive Plan (Filed With SEC on January 6, 2012)

ARGOS THERAPEUTICS, INC. 2011 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 6, 2012)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on September 2, 2011)

SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 29, 2011)

WARRANT TO PURCHASE SHARES OF COMMON STOCK Expires October 31, 2012 (Filed With SEC on July 29, 2011)

WARRANT TO PURCHASE SHARES OF COMMON STOCK Expires February 5, 2013 (Filed With SEC on July 29, 2011)

ARGOS THERAPEUTICS, INC. STOCK OPTION PLAN (Filed With SEC on July 29, 2011)

ARGOS THERAPEUTICS, INC. 2008 STOCK INCENTIVE PLAN (Filed With SEC on July 29, 2011)

ARGOS THERAPEUTICS, INC. NOTICE OF INCENTIVE STOCK OPTION 2008 STOCK INCENTIVE PLAN (Filed With SEC on July 29, 2011)

ARGOS THERAPEUTICS, INC. NOTICE OF NONSTATUTORY STOCK OPTION 2008 STOCK INCENTIVE PLAN (Filed With SEC on July 29, 2011)

Employee Action Form (Filed With SEC on July 29, 2011)

AGREEMENT (Filed With SEC on July 29, 2011)

Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on July 29, 2011)

Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT - TREATING AUTOIMMUNE... (Filed With SEC on July 29, 2011)

Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT (Anti-Interferon Alpha... (Filed With SEC on July 29, 2011)

Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on July 29, 2011)

Category

Industry

Companies

Contracts

ARGOS THERAPEUTICS INC Contracts & Agreements